Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick W Mallon

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Biochemical and Biophysical Research Communications|November 21, 2020
COVID19- clinical presentation and therapeutic considerationsGrace Kenny, Patrick W Mallon
Respirology (Carlton, Vic.)|September 21, 2020
ReplyStefano Savinelli, Cormac McCarthy, Patrick W Mallon, et al.
PPAR Research|March 28, 2009
Is PPARγ a prospective player in HIV-1-associated bone disease?Eoin J Cotter, Patrick W Mallon, Peter P Doran
AIDS (London, England)|April 18, 2003
Prospective evaluation of the effects of antiretroviral therapy on body composition in HIV-1-infected men starting therapyPatrick W Mallon, John Miller, David A Cooper, et al.
AIDS Research and Human Retroviruses|March 27, 2009
Darunavir concentrations in cerebrospinal fluid and blood in HIV-1-infected individualsAylin Yilmaz, Arash Izadkhashti, Richard W Price, et al.
Plos One|December 9, 2024
HIV, the gut microbiome and clinical outcomes, a systematic reviewRachel Mac Cann, Ellen Newman, Declan Devane, et al.
AIDS (London, England)|August 18, 2022
Obesity in HIV infection: host-pathogen interactionStefano Savinelli, Neil E Wrigley Kelly, Eoin R Feeney, et al.
AIDS Research and Human Retroviruses|June 9, 2009
Evolution of CD4+ T cell count in HIV-1-infected adults receiving antiretroviral therapy with sustained long-term virological suppressionHelen Byakwaga, John M Murray, Kathy Petoumenos, et al.
The Journal of General Virology|February 14, 2023
A novel antiviral formulation containing caprylic acid inhibits SARS-CoV-2 infection of a human bronchial epithelial cell modelKevin Purves, Ruth Haverty, Tiina O'Neill, et al.
AIDS (London, England)|April 21, 2020
Investigating the effect of antiretroviral switch to tenofovir alafenamide on lipid profiles in people living with HIVAoife Lacey, Stefano Savinelli, Elena Alvarez Barco, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Biochemical and Biophysical Research Communications|November 21, 2020
COVID19- clinical presentation and therapeutic considerationsGrace Kenny, Patrick W Mallon
Respirology (Carlton, Vic.)|September 21, 2020
ReplyStefano Savinelli, Cormac McCarthy, Patrick W Mallon, et al.
PPAR Research|March 28, 2009
Is PPARγ a prospective player in HIV-1-associated bone disease?Eoin J Cotter, Patrick W Mallon, Peter P Doran
AIDS (London, England)|April 18, 2003
Prospective evaluation of the effects of antiretroviral therapy on body composition in HIV-1-infected men starting therapyPatrick W Mallon, John Miller, David A Cooper, et al.
AIDS Research and Human Retroviruses|March 27, 2009
Darunavir concentrations in cerebrospinal fluid and blood in HIV-1-infected individualsAylin Yilmaz, Arash Izadkhashti, Richard W Price, et al.
Plos One|December 9, 2024
HIV, the gut microbiome and clinical outcomes, a systematic reviewRachel Mac Cann, Ellen Newman, Declan Devane, et al.
AIDS (London, England)|August 18, 2022
Obesity in HIV infection: host-pathogen interactionStefano Savinelli, Neil E Wrigley Kelly, Eoin R Feeney, et al.
AIDS Research and Human Retroviruses|June 9, 2009
Evolution of CD4+ T cell count in HIV-1-infected adults receiving antiretroviral therapy with sustained long-term virological suppressionHelen Byakwaga, John M Murray, Kathy Petoumenos, et al.
The Journal of General Virology|February 14, 2023
A novel antiviral formulation containing caprylic acid inhibits SARS-CoV-2 infection of a human bronchial epithelial cell modelKevin Purves, Ruth Haverty, Tiina O'Neill, et al.
AIDS (London, England)|April 21, 2020
Investigating the effect of antiretroviral switch to tenofovir alafenamide on lipid profiles in people living with HIVAoife Lacey, Stefano Savinelli, Elena Alvarez Barco, et al.
Pageof 3